Considering these data, we hypothesised that increased FOXE1 expression in thyroid carcinomas could be related to a motile advantage of malignant thyroid cells, which would be enhanced by the presence of the rs1867277 A risk predisposing allele. The gene discussed is FOXE1; the disease is thyroid gland carcinoma.